FOLEY HOAG LLP for AMGEN
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Medicare Part D; Medicare coverage policy for chronic renal disease; Medicare Part B reimbursement and coverage of dialysis products; Congressional deficit reduction negotiations and Deficit Reduction Commission, following passage of the Budget Control Act of 2011 (P.L. 112-25)
| Lobbyist | Covered position, as disclosed |
|---|---|
| J KEVIN BRENNAN | — |
| PAUL KIM | — |
| NICK LITTLEFIELD | — |
Health Issues HCR
Implementation of P.L. 111-148, Patient Protection and Affordable Care Act and Implementation of P.L. 111-152, Health Care and Education Reconciliation Act (Biosimilars); (Independent Payment Advisory Board "IPAB"); Reauthorization of the Prescription Drug User Fee Act; Budget Control Act of 2011 (P.L. 112-25)
| Lobbyist | Covered position, as disclosed |
|---|---|
| J KEVIN BRENNAN | — |
| PAUL KIM | — |
| NICK LITTLEFIELD | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.